The AB SCIEX TripleTOF® 5600+ System is an innovative breakthrough in LC/MS/MS performance that uniquely integrates comprehensive qualitative exploration, rapid profiling, and high-resolution quantitation workflows on a single platform. It combines the highest sensitivity detection, high-resolution with the fastest acquisition speeds, and stable ~2ppm mass accuracy over days of acquisition.
Expanding upon the capabilities of TripleTOF technology, 5600+ provides broader applicability in pharma and a new paradigm in proteomics research.
MS/MSALL with SWATHTM Acquisition - enabling comprehensive MS/MS quantitation in proteomics
Tools for 21 CFR 11 Compliance in Analyst® TF 1.6 and MultiQuantTM Software, bringing the power of accurate mass to regulated bioanalysis
Optional SelexIONTM Technology - for an additional dimension of separation
High resolution at unparalleled speed - up to 40,000 FWHM with 10 msec accumulation time
EasyMassTM Accuracy - without continuous recalibration - over 50 hours of continuous LC/MS operation provides <2 ppm RMS
SmartSpeedTM 100Hz Acquisition delivering high-resolution for high-speed chromatography - up to 100 spectra in a second – even in Information Dependent Acquisition (IDA).
Most sensitive high resolution system - lowest limits of quantitation (LOQ) for a high resolution system and equivalent to high-performance triple quads.
Food Triggers Creation of Regulatory T Cells IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.Light Signals from Living Cells Fluorescent protein markers delivered under high pressure.Counting Cancer-busting Oxygen Molecules Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.Therapeutic Approach Gives Hope for Multiple Myeloma A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.Cellular 'Relief Valve' A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.Genomic Signature Shared by Five Types of Cancer National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer. Protein Protects Against Flu in Mice The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.Cat Stem Cell Therapy Gives Humans Hope By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives. Crowdfunding the Fight Against Cancer From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Switch Lets Salmonella Fight, Evade Immune System Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.